Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$77K Sell
1,192
-937
-44% -$66.1K 0.05% 421
2025
Q4
$143K Sell
2,129
-218
-9% -$14.7K 0.07% 368
2025
Q3
$172K Buy
2,347
+379
+19% +$25.2K 0.09% 274
2025
Q2
$102K Sell
1,968
-781
-28% -$44.4K 0.06% 541
2025
Q1
$175K Buy
2,749
+1,228
+81% +$71.3K 0.12% 197
2024
Q4
$73K Sell
1,521
-256
-14% -$13.1K 0.05% 691
2024
Q3
$102K Sell
1,777
-275
-13% -$15.8K 0.06% 502
2024
Q2
$107K Sell
2,052
-521
-20% -$22.8K 0.07% 439
2024
Q1
$105K Buy
2,573
+1,476
+135% +$55.3K 0.07% 512
2023
Q4
$41K Buy
1,097
+482
+78% +$18.2K 0.03% 935
2023
Q3
$24K Sell
615
-307
-33% -$12.6K 0.02% 1046
2023
Q2
$33K Buy
922
+637
+224% +$21.7K 0.03% 945
2023
Q1
$11K Sell
285
-768
-73% -$36K 0.01% 1264
2022
Q4
$60K Sell
1,053
-715
-40% -$36.6K 0.05% 651
2022
Q3
$70K Buy
1,768
+1,087
+160% +$48K 0.06% 550
2022
Q2
$30K Sell
681
-980
-59% -$42.4K 0.02% 886
2022
Q1
$66K Sell
1,661
-1,166
-41% -$41.5K 0.04% 704
2021
Q4
$114K Buy
+2,827
New +$106K 0.16% 119

Other funds holding HALO

Covestor's HALO Position: Q1 2026 in Review

Covestor reduced its Halozyme (HALO) stake by 44% in Q1 2026, selling an estimated $66.1K and leaving 1,192 shares worth $77K. The position accounts for 0.05% of the portfolio, ranked #421.

Covestor first reported a position in HALO in Q4 2021 and has held it in 18 quarters since. The position peaked at $175K in Q1 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Covestor held 1,192 shares of Halozyme worth $77K as of Q1 2026.
  • Covestor sold 937 Halozyme shares in Q1 2026, an estimated $66.1K.
  • Halozyme made up 0.05% of Covestor's portfolio in Q1 2026, its #421 holding.
  • Covestor first reported a position in Halozyme in Q4 2021 and has held it in 18 quarters since.
  • Covestor's Halozyme position peaked at $175K in Q1 2025.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.